Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 152

1.

An Efficient Analytic Approach for Calculation of Multi-Dimensional Franck-Condon Factors and Associated Photoelectron Spectra.

Sattasathuchana T, Murri R, Baldridge KK.

J Chem Theory Comput. 2017 Apr 12. doi: 10.1021/acs.jctc.7b00142. [Epub ahead of print]

PMID:
28402636
2.

Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series.

Murri R, Fiori B, Spanu T, Mastrorosa I, Giovannenze F, Taccari F, Palazzolo C, Scoppettuolo G, Ventura G, Sanguinetti M, Cauda R, Fantoni M.

Infection. 2017 Apr;45(2):209-213. doi: 10.1007/s15010-016-0968-x. Epub 2017 Feb 9.

PMID:
28185222
3.

Nursing home residence is associated with spread of Clostridium difficile ribotype 027 in central Italy.

Falcone M, Iraci F, Raponi G, Goldoni P, Belvisi V, Delle Rose D, Santino I, Murri R, Fantoni M, Carfagna P, Sanguinetti M, Fontana C, Farcomeni A, Tiseo G, Aceti A, Cauda R, Vullo V, Mastroianni CM, Andreoni M, Venditti M.

J Hosp Infect. 2016 Oct;94(2):201-3. doi: 10.1016/j.jhin.2016.06.024. Epub 2016 Jul 30. No abstract available.

PMID:
27546454
4.

Impact of antibiotic stewardship on perioperative antimicrobial prophylaxis.

Murri R, de Belvis AG, Fantoni M, Tanzariello M, Parente P, Marventano S, Bucci S, Giovannenze F, Ricciardi W, Cauda R, Sganga G; collaborative SPES Group..

Int J Qual Health Care. 2016 Sep;28(4):502-7. doi: 10.1093/intqhc/mzw055. Epub 2016 Jun 9.

PMID:
27283440
5.

Validation of a self-reported HIV symptoms list: the ISS-HIV symptoms scale.

Bucciardini R, Pugliese K, Francisci D, Costantini A, Schiaroli E, Cognigni M, Tontini C, Lucattini S, Fucili L, Di Gregorio M, Mirra M, Fragola V, Pompili S, Murri R, Vella S.

AIDS Res Ther. 2016 Apr 9;13:18. doi: 10.1186/s12981-016-0102-2. eCollection 2016.

6.

Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.

Lambert-Niclot S, George EC, Pozniak A, White E, Schwimmer C, Jessen H, Johnson M, Dunn D, Perno CF, Clotet B, Plettenberg A, Blaxhult A, Palmisano L, Wittkop L, Calvez V, Marcelin AG, Raffi F; NEAT 001/ANRS 143 Study Group..

J Antimicrob Chemother. 2016 Apr;71(4):1056-62. doi: 10.1093/jac/dkv427. Epub 2015 Dec 24.

PMID:
26702926
7.

Initial antifungal strategy does not correlate with mortality in patients with candidemia.

Murri R, Scoppettuolo G, Ventura G, Fabbiani M, Giovannenze F, Taccari F, Milozzi E, Posteraro B, Sanguinetti M, Cauda R, Fantoni M.

Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):187-93. doi: 10.1007/s10096-015-2527-2. Epub 2015 Dec 3.

PMID:
26634352
8.

The SIB Swiss Institute of Bioinformatics' resources: focus on curated databases.

SIB Swiss Institute of Bioinformatics Members..

Nucleic Acids Res. 2016 Jan 4;44(D1):D27-37. doi: 10.1093/nar/gkv1310. Epub 2015 Nov 28.

9.

Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.

Winston A, Stöhr W, Antinori A, Arenas-Pinto A, Llibre JM, Amieva H, Cabié A, Williams I, Di Perri G, Tellez MJ, Rockstroh J, Babiker A, Pozniak A, Raffi F, Richert L; NEAT 001/Agence Nationale de Recherche sur le SIDA (ANRS) 143 Study Group..

HIV Med. 2016 Jun;17(6):471-8. doi: 10.1111/hiv.12344. Epub 2015 Nov 26.

PMID:
26611175
10.

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.

Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buño A, Castagna A, Girard PM, Chene G, Raffi F, Arribas JR; NEAT001/ANRS143 Study Group..

Lancet HIV. 2015 Nov;2(11):e464-73. doi: 10.1016/S2352-3018(15)00181-2. Epub 2015 Sep 30.

PMID:
26520926
11.

Liver Resection for Primary Intrahepatic Stones: Focus on Postoperative Infectious Complications.

Clemente G, De Rose AM, Murri R, Ardito F, Nuzzo G, Giuliante F.

World J Surg. 2016 Feb;40(2):433-9. doi: 10.1007/s00268-015-3227-x.

PMID:
26330236
12.

Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection.

Fabbiani M, Di Giambenedetto S, Cingolani A, Fanti I, Colafigli M, Tamburrini E, Cauda R, Navarra P, De Luca A, Murri R.

Infect Dis (Lond). 2016;48(1):48-55. doi: 10.3109/23744235.2015.1082034. Epub 2015 Sep 2.

PMID:
26329383
13.

TRAL: tandem repeat annotation library.

Schaper E, Korsunsky A, Pečerska J, Messina A, Murri R, Stockinger H, Zoller S, Xenarios I, Anisimova M.

Bioinformatics. 2015 Sep 15;31(18):3051-3. doi: 10.1093/bioinformatics/btv306. Epub 2015 May 18.

PMID:
25987568
14.

Defining needs and goals of post-ICU care for trauma patients: preliminary study.

Bocci MG, Grieco DL, Lochi S, Minguell Del Lungo L, Pintaudi G, Caricato A, Murri R, Calabrese C, DE Belvis AG, Avolio M, Sandroni C, Antonelli M.

Minerva Anestesiol. 2016 Jan;82(1):22-9. Epub 2015 Apr 15.

15.

Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection.

Russo A, Falcone M, Fantoni M, Murri R, Masucci L, Carfagna P, Ghezzi MC, Posteraro B, Sanguinetti M, Venditti M.

Clin Microbiol Infect. 2015 May;21(5):493.e1-4. doi: 10.1016/j.cmi.2014.12.024. Epub 2015 Jan 14.

16.

Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model?

Fantoni M, Murri R, Scoppettuolo G, Fabbiani M, Ventura G, Losito R, Berloco F, Spanu T, Sanguinetti M, Cauda R.

Future Microbiol. 2015;10(1):15-20. doi: 10.2217/fmb.14.99.

PMID:
25598334
17.

Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.

Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chêne G, Pozniak A; NEAT001/ANRS143 Study Group..

Lancet. 2014 Nov 29;384(9958):1942-51. doi: 10.1016/S0140-6736(14)61170-3. Epub 2014 Aug 4.

PMID:
25103176
18.

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.

Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, Lundgren JD; D:A:D Study Group..

Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8.

PMID:
25042234
19.

Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study.

Marchetti G, Cozzi-Lepri A, Tincati C, Calcagno A, Ceccherini-Silberstein F, De Luca A, Antinori A, Castagna A, Puoti M, Monforte Ad; Icona Foundation Study Group..

BMC Infect Dis. 2014 Feb 12;14:79. doi: 10.1186/1471-2334-14-79.

20.

Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study).

Fabbiani M, Mondi A, Colafigli M, D'Ettorre G, Paoletti F, D'Avino A, Ciccarelli N, Sidella L, Murri R, Fortuna S, Vullo V, Cauda R, De Luca A, Di Giambenedetto S.

Scand J Infect Dis. 2014 Jan;46(1):34-45. doi: 10.3109/00365548.2013.840920. Epub 2013 Oct 28.

PMID:
24161018

Supplemental Content

Loading ...
Support Center